AP3480A - Phosphaplatins and their use for treatment of cancers - Google Patents
Phosphaplatins and their use for treatment of cancersInfo
- Publication number
- AP3480A AP3480A AP2012006594A AP2012006594A AP3480A AP 3480 A AP3480 A AP 3480A AP 2012006594 A AP2012006594 A AP 2012006594A AP 2012006594 A AP2012006594 A AP 2012006594A AP 3480 A AP3480 A AP 3480A
- Authority
- AP
- ARIPO
- Prior art keywords
- phosphaplatins
- cancers
- treatment
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35151410P | 2010-06-04 | 2010-06-04 | |
| PCT/US2011/038948 WO2011153365A1 (en) | 2010-06-04 | 2011-06-02 | Phosphaplatins and their use for treatment of cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2012006594A0 AP2012006594A0 (en) | 2012-12-31 |
| AP3480A true AP3480A (en) | 2015-12-31 |
Family
ID=44627266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2012006594A AP3480A (en) | 2010-06-04 | 2011-06-02 | Phosphaplatins and their use for treatment of cancers |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US9688709B2 (pl) |
| EP (1) | EP2575802B1 (pl) |
| JP (1) | JP5860872B2 (pl) |
| KR (1) | KR101775410B1 (pl) |
| CN (6) | CN103037859A (pl) |
| AP (1) | AP3480A (pl) |
| AU (1) | AU2011261381B2 (pl) |
| BR (1) | BR112012030927B1 (pl) |
| CA (1) | CA2800898C (pl) |
| CL (1) | CL2012003416A1 (pl) |
| CO (1) | CO6640302A2 (pl) |
| CY (1) | CY1118466T1 (pl) |
| DK (1) | DK2575802T3 (pl) |
| EA (1) | EA021526B1 (pl) |
| ES (1) | ES2606855T3 (pl) |
| HR (1) | HRP20170225T1 (pl) |
| HU (1) | HUE030249T2 (pl) |
| IL (1) | IL223405B (pl) |
| LT (1) | LT2575802T (pl) |
| MX (1) | MX2012014174A (pl) |
| MY (1) | MY162902A (pl) |
| NZ (1) | NZ603952A (pl) |
| PL (1) | PL2575802T3 (pl) |
| PT (1) | PT2575802T (pl) |
| RS (1) | RS55714B1 (pl) |
| SG (1) | SG185722A1 (pl) |
| SI (1) | SI2575802T1 (pl) |
| SM (1) | SMT201700056B (pl) |
| WO (1) | WO2011153365A1 (pl) |
| ZA (1) | ZA201209007B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5860872B2 (ja) | 2010-06-04 | 2016-02-16 | オハイオ ユニバーシティー | ホスファプラチン、及び癌治療のためのそれらの使用 |
| EP2663301A1 (en) * | 2011-01-12 | 2013-11-20 | Ohio University | Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
| WO2013052839A1 (en) * | 2011-10-05 | 2013-04-11 | Bose Rathindra N | Efficient processes for large scale preparation of phosphaplatins antitumor agents |
| EP2763537B1 (en) * | 2011-10-05 | 2018-01-10 | Rathindra N. Bose | Efficient processes for large scale preparation of phosphaplatins antitumor agents |
| DK2855496T3 (en) * | 2012-05-24 | 2017-03-27 | Phosplatin Therapeutics Llc | PROCEDURES FOR SYNTHESIS AND PURIFICATION OF PHOSPHAPLATIN COMPOUNDS AND APPLICATIONS THEREOF |
| US9333211B2 (en) * | 2013-02-22 | 2016-05-10 | University Of Houston System | Phosphaplatin mediated modulation of pigment epithelial derived factor and uses thereof |
| US20150231151A1 (en) * | 2014-02-19 | 2015-08-20 | University Of Houston System | Compositions and methods for the treatment of neurodegenerative diseases |
| US11154529B2 (en) * | 2016-04-06 | 2021-10-26 | Phosplatin Therapeutics Inc. | Phosphaplatin liquid formulations |
| EP3565561A4 (en) * | 2017-01-06 | 2020-08-26 | Phosplatin Therapeutics LLC | PHOSPHAPLATIN COMPOUNDS AS THERAPEUTICS FOR THE TREATMENT OF BONE / BLOOD CANCER |
| CN111328330B (zh) * | 2017-09-08 | 2024-03-08 | 普罗蒙托里治疗有限公司 | 作为免疫调节剂的磷铂化合物及其治疗用途 |
| WO2022087173A1 (en) * | 2020-10-20 | 2022-04-28 | Phosplatin Therapeutics Inc. | Phosphaplatin compounds as therapeutic agents selectively targeting highly glycolytic tumor cells and methods thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009021081A2 (en) * | 2007-08-06 | 2009-02-12 | Ohio University | Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4234500A (en) | 1979-03-07 | 1980-11-18 | Engelhard Minerals & Chemicals Corporation | Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes |
| US4291027A (en) | 1979-03-07 | 1981-09-22 | Engelhard Minerals & Chemicals Corp. | Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes |
| CA2017739A1 (en) | 1989-07-18 | 1991-01-18 | Leslie S. Hollis | Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents |
| AUPR330201A0 (en) | 2001-02-23 | 2001-03-22 | University Of Sydney, The | Metal complexes and therapeutic uses thereof |
| DE10314780A1 (de) | 2003-03-19 | 2004-09-30 | Ktb Tumorforschungsgesellschaft Mbh | Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden |
| AU2004235781A1 (en) * | 2003-05-02 | 2004-11-18 | Aronex Pharmaceuticals, Inc. | Lipid platinum complexes and methods of use thereof |
| EP1644388A2 (en) | 2003-06-27 | 2006-04-12 | ODANI, Akira | Bisphosphonate complexes |
| JPWO2009008345A1 (ja) | 2007-07-06 | 2010-09-09 | 久雄 浴本 | 金属錯体化合物、これを有効成分とする癌治療剤組成物および該金属錯体化合物用の中間体 |
| WO2011125911A1 (ja) * | 2010-03-31 | 2011-10-13 | 国立大学法人金沢大学 | 金属錯体およびこれを有効成分として含有する抗がん剤 |
| JP5860872B2 (ja) | 2010-06-04 | 2016-02-16 | オハイオ ユニバーシティー | ホスファプラチン、及び癌治療のためのそれらの使用 |
| EP2663301A1 (en) | 2011-01-12 | 2013-11-20 | Ohio University | Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof |
| EP2763537B1 (en) * | 2011-10-05 | 2018-01-10 | Rathindra N. Bose | Efficient processes for large scale preparation of phosphaplatins antitumor agents |
-
2011
- 2011-06-02 JP JP2013513350A patent/JP5860872B2/ja active Active
- 2011-06-02 ES ES11726567.8T patent/ES2606855T3/es active Active
- 2011-06-02 PT PT117265678T patent/PT2575802T/pt unknown
- 2011-06-02 AU AU2011261381A patent/AU2011261381B2/en active Active
- 2011-06-02 CN CN2011800387165A patent/CN103037859A/zh active Pending
- 2011-06-02 SG SG2012086229A patent/SG185722A1/en unknown
- 2011-06-02 MX MX2012014174A patent/MX2012014174A/es active IP Right Grant
- 2011-06-02 CN CN201810150598.0A patent/CN108186651A/zh active Pending
- 2011-06-02 CN CN201810150614.6A patent/CN108299508A/zh active Pending
- 2011-06-02 CN CN201810150496.9A patent/CN108409795A/zh active Pending
- 2011-06-02 HU HUE11726567A patent/HUE030249T2/en unknown
- 2011-06-02 NZ NZ603952A patent/NZ603952A/en unknown
- 2011-06-02 PL PL11726567T patent/PL2575802T3/pl unknown
- 2011-06-02 KR KR1020137000158A patent/KR101775410B1/ko not_active Application Discontinuation
- 2011-06-02 CA CA2800898A patent/CA2800898C/en active Active
- 2011-06-02 EA EA201270812A patent/EA021526B1/ru unknown
- 2011-06-02 CN CN201810150487.XA patent/CN108210516A/zh active Pending
- 2011-06-02 WO PCT/US2011/038948 patent/WO2011153365A1/en active Application Filing
- 2011-06-02 RS RS20170139A patent/RS55714B1/sr unknown
- 2011-06-02 BR BR112012030927-7A patent/BR112012030927B1/pt active IP Right Grant
- 2011-06-02 SI SI201131103A patent/SI2575802T1/sl unknown
- 2011-06-02 EP EP11726567.8A patent/EP2575802B1/en active Active
- 2011-06-02 US US13/701,313 patent/US9688709B2/en active Active
- 2011-06-02 CN CN201810150470.4A patent/CN108392490A/zh active Pending
- 2011-06-02 MY MYPI2012005178A patent/MY162902A/en unknown
- 2011-06-02 LT LTEP11726567.8T patent/LT2575802T/lt unknown
- 2011-06-02 DK DK11726567.8T patent/DK2575802T3/en active
- 2011-06-02 AP AP2012006594A patent/AP3480A/xx active
-
2012
- 2012-11-28 ZA ZA2012/09007A patent/ZA201209007B/en unknown
- 2012-12-03 IL IL223405A patent/IL223405B/en active IP Right Grant
- 2012-12-04 CO CO12219958A patent/CO6640302A2/es not_active Application Discontinuation
- 2012-12-04 CL CL2012003416A patent/CL2012003416A1/es unknown
-
2016
- 2016-12-22 CY CY20161101332T patent/CY1118466T1/el unknown
-
2017
- 2017-01-25 SM SM201700056T patent/SMT201700056B/it unknown
- 2017-02-10 HR HRP20170225TT patent/HRP20170225T1/hr unknown
- 2017-05-24 US US15/604,209 patent/US10385083B2/en active Active
- 2017-05-24 US US15/604,237 patent/US10364264B2/en active Active
-
2019
- 2019-06-26 US US16/453,303 patent/US10759820B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009021081A2 (en) * | 2007-08-06 | 2009-02-12 | Ohio University | Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin |
Non-Patent Citations (2)
| Title |
|---|
| BOSE RATHINDRA N ET AL: "Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 105, no. 47, 25 November 2008 (2008-11-25), pages 18314 - 18319,1292 * |
| MISHUR ROBERT J ET AL: "Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.", INORGANIC CHEMISTRY, vol. 47, no. 18, 15 September 2008 (2008-09-15), pages 7972 - 7982 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276362A (en) | Cancer treatment methods | |
| IL248530A0 (en) | Biomarkers and treatment methods | |
| HRP20170225T1 (hr) | Fosfoplatini i njihova uporaba za liječenje karcinoma | |
| HRP20171352T1 (hr) | Wnt-antagonisti i postupci liječenja | |
| ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
| SG10201508495VA (en) | Combination treatment of cancer | |
| IL222227A0 (en) | Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use | |
| EP2539005A4 (en) | ORAL PIECE AND METHODS OF USING THE SAME | |
| ZA201300218B (en) | Treatment of blood cancer | |
| HK1189272A1 (zh) | 治療癌症的方法 | |
| EP2574172A4 (en) | MATERIALS AND METHOD FOR TREATING INFLAMMATION | |
| IL256026B (en) | Treatment methods | |
| EP2640390A4 (en) | METHODS OF TREATING CANCER | |
| EP2547368A4 (en) | METHOD AND COMPOSITIONS FOR CANCER TREATMENT | |
| EP2709730A4 (en) | TREATMENT AND PROGNOSIS OF CANCER | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| EP2574194A4 (en) | MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT | |
| GB201017354D0 (en) | Treatment of cancer | |
| GB201017356D0 (en) | Combination treatment of cancer | |
| GB201002499D0 (en) | Treatment of tumours | |
| HUP1000688A2 (en) | Use of trifluoro-phthalimides in the treatment of cancer | |
| ZA201301175B (en) | Biomarkers and methods of treatment |